A Supreme Court ruling will temporarily prevent the enforcement of FDA restrictions that require women to pick up an abortion pill from the doctor during the coronavirus pandemic and will instead allow the medication to be mailed, according to NPR.
The decision lets women continue to get an abortion pill by mail after the high court pushed the case back down to a Maryland federal court for further review.
Three months ago, a federal judge in Maryland decided healthcare providers can have mifepristone mailed to patients. The drug was approved by the FDA in combination with misoprostol to terminate an early pregnancy.
American College of Obstetricians and Gynecologists challenged the FDA regulation since the agency has eased similar restrictions for medications such as opioids.
"It is a relief that for the next few weeks the Trump administration cannot force abortion patients to needlessly risk contracting a life-threatening disease as a condition of obtaining care," said Julia Kaye, lead counsel for ACOG. "When President Trump is trying to rush through a third Supreme Court justice with the express goal of overturning Roe v. Wade, the court's delayed ruling in this case gives little comfort that the right to abortion is secure."
The Supreme Court asked for the Maryland federal judge to reevaluate the rule within 40 days, keeping the high court from acting any more on the issue until after the election.
© 2024 Newsmax. All rights reserved.